Reported positive data from the Phase II MAvERIC-Pilot study investigating the impact of CardiolRx™ administered to patients with symptomatic recurrent pericarditis; results support advancing to the ...
Appointment of seven recognized experts is validating for Ventyx’s NLRP3 Program--AD/PD™ 2025 provides helpful insights on potential next steps in Parkinson’s disease SAN DIEGO, April 01, 2025 (GLOBE ...
Main pulmonary artery diameter is a prognostic indicator in patients with pulmonary arterial hypertension without congenital heart disease.
Elizabeth Knowles’ baby sister, Jermeek Rolle, is her hero – literally. She donated a kidney to her sister who was in end ...
Heartwater is widely spread in Africa but the Amblyoma tick may be found in areas where the disease organisms are not present ...
The Business Research Company The Business Research Company's Myocarditis Disease Global Market Report 2025 – Market Size, Trends, And Glob ...
Emergent BioSolutions struggles with declining revenues, rising competition, and weak growth prospects. Read why I rate EBS ...
IT’S only normal to change a little from mid-life – greying hair, wrinkles, aching limbs and the odd ‘senior moment’. But some symptoms usually associated with ageing shouldn’t just be ...
AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...
Charles Schwab Investment Management Inc. raised its holdings in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by ...
Carly Pearce has been an open book since first revealing her serious heart issue with fans last year, and this week she shared some more about her health and how she was diagnosed. The 34-year-old ...
Cardiol Therapeutics Inc. (TSE:CRDL – Get Free Report)’s share price traded down 5% during mid-day trading on Tuesday . The stock traded as low as C$1.51 and last traded at C$1.52. 86,322 shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results